We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TROY STEPS DOWN; MASOUDI NAMED ACTING CHIEF COUNSEL
TROY STEPS DOWN; MASOUDI NAMED ACTING CHIEF COUNSEL
December 2, 2004
FDA newcomer Gerald Masoudi took over as the FDA’s acting chief counsel Nov. 28, replacing Daniel Troy, who announced Nov. 16 that he was leaving the agency.